Jump Financial, LLC Avidity Biosciences, Inc. Transaction History

Jump Financial, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Oct 21, 2024	SELL	$4.87 - $9.37 $195,252 - $375,671	-40,093 Reduced 36.22%	70,594 $638,000
Q4 2023 Feb 07, 2024	SELL	$4.87 - $9.37 $195,252 - $375,671	-40,093 Reduced 36.22%	70,594 $638,000
Q3 2023 Oct 21, 2024	BUY	$6.3 - $11.35 $86,738 - $156,266	13,768 Added 14.21%	110,687 $706,000
Q3 2023 Nov 07, 2023	BUY	$6.3 - $11.35 $86,738 - $156,266	13,768 Added 14.21%	110,687 $706,000
Q2 2023 Oct 21, 2024	BUY	$10.62 - $17.34 $1.03 Million - $1.68 Million	96,919 New	96,919 $1.07 Million
Q2 2023 Aug 07, 2023	BUY	$10.62 - $17.34 $1.03 Million - $1.68 Million	96,919 New	96,919 $1.07 Million
Q4 2022 Feb 13, 2023	BUY	$10.06 - $22.66 $117,651 - $265,008	11,695 New	11,695 $259,000

250

107M

224K

161K

Ticker RNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,127,000
Market Cap $1.74B
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.